AWH insider transaction filings
Aspira Women's Health Inc. — 11 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2025-05-27. Screen AWH transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2025-05-27 | 4 | Buhle Michael William — Chief Executive Officer | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2025-04-02 | 4 | Vos Ellen O'Connor — Director | Option exercise (M): 5,313 @ $0 · Option exercise (M): 5,313 (derivative) @ $0 | EDGAR |
| 2025-04-01 | 4 | Beausang Ellen — Director | Option exercise (M): 1,615 @ $0 · Option exercise (M): 1,615 (derivative) @ $0 | EDGAR |
| 2025-04-01 | 4 | Beausang Ellen — Director | Grant/award (A): 6,458 (derivative) @ $0 | EDGAR |
| 2025-04-01 | 4 | Ragard John Phillip — Director | Option exercise (M): 4,843 @ $0 · Option exercise (M): 4,843 (derivative) @ $0 | EDGAR |
| 2025-04-01 | 4 | Parnell Winfred — Director | Option exercise (M): 5,156 @ $0 · Option exercise (M): 5,156 (derivative) @ $0 | EDGAR |
| 2025-04-01 | 4 | Herchuk Jannie Prestridge — Director | Option exercise (M): 8,438 @ $0 · Option exercise (M): 8,438 (derivative) @ $0 | EDGAR |
| 2025-04-01 | 4 | Fralick Celeste Rachelle — Director | Option exercise (M): 5,000 @ $0 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2025-04-01 | 4 | Cavanaugh Stefanie L. — Director | Option exercise (M): 5,938 @ $0 · Option exercise (M): 5,938 (derivative) @ $0 | EDGAR |
| 2025-03-10 | 4 | SCHULER JACK W — 10% owner | Purchase (P) @ $200,000 | EDGAR |
| 2025-01-29 | 4/A | Milligan Sandra — Interim CEO | Option exercise (M): 20,000 @ $0 · Tax withholding (F): 6,356 @ $0.70 · Option exercise (M): 20,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — Aspira Women's Health Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-07-15 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-07 | 8-K/A | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-22 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-06-17 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-06-09 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-26 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-30 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-03-25 | 8-K/A | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-30 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-12-31 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=AWH returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →